María U. Moreno

3.4k total citations · 1 hit paper
49 papers, 2.6k citations indexed

About

María U. Moreno is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Immunology. According to data from OpenAlex, María U. Moreno has authored 49 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 18 papers in Physiology and 18 papers in Immunology. Recurrent topics in María U. Moreno's work include Nitric Oxide and Endothelin Effects (16 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (14 papers) and Cardiac Fibrosis and Remodeling (8 papers). María U. Moreno is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (14 papers) and Cardiac Fibrosis and Remodeling (8 papers). María U. Moreno collaborates with scholars based in Spain, United Kingdom and United States. María U. Moreno's co-authors include Javier Dı́ez, Gorka San José, Guillermo Zalba, Ana Fortuño, Javier Beaumont, Arantxa González, Begoña López, Óscar Beloqui, Susana Ravassa and Ramón Querejeta and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes and Scientific Reports.

In The Last Decade

María U. Moreno

49 papers receiving 2.6k citations

Hit Papers

Diffuse myocardial fibrosis: mechanisms, diagnosis and th... 2021 2026 2022 2024 2021 50 100 150 200

Peers

María U. Moreno
María U. Moreno
Citations per year, relative to María U. Moreno María U. Moreno (= 1×) peers Gorka San José

Countries citing papers authored by María U. Moreno

Since Specialization
Citations

This map shows the geographic impact of María U. Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María U. Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María U. Moreno more than expected).

Fields of papers citing papers by María U. Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María U. Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María U. Moreno. The network helps show where María U. Moreno may publish in the future.

Co-authorship network of co-authors of María U. Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of María U. Moreno. A scholar is included among the top collaborators of María U. Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María U. Moreno. María U. Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravassa, Susana, Josep Lupón, Begoña López, et al.. (2022). Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides. JACC Heart Failure. 11(1). 58–72. 11 indexed citations
2.
López, Begoña, Susana Ravassa, María U. Moreno, et al.. (2021). Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nature Reviews Cardiology. 18(7). 479–498. 215 indexed citations breakdown →
3.
Santer, Laura, Begoña López, Susana Ravassa, et al.. (2019). Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease. Hypertension. 73(4). 820–828. 39 indexed citations
4.
Miguel‐Carrasco, José L., Javier Beaumont, Gorka San José, et al.. (2017). Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites. Scientific Reports. 7(1). 41865–41865. 27 indexed citations
5.
López, Begoña, Susana Ravassa, Arantxa González, et al.. (2016). Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure. Journal of the American College of Cardiology. 67(3). 251–260. 110 indexed citations
6.
Moreno, María U., Rocío Eirós, Juán José Gavira, et al.. (2016). The Hypertensive Myocardium. Medical Clinics of North America. 101(1). 43–52. 27 indexed citations
7.
Gallego, Idoia, Javier Beaumont, Begoña López, et al.. (2016). Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients. Clinical Science. 130(23). 2139–2149. 10 indexed citations
8.
López, Begoña, Arantxa González, Susana Ravassa, et al.. (2015). Circulating Biomarkers of Myocardial Fibrosis. Journal of the American College of Cardiology. 65(22). 2449–2456. 196 indexed citations
9.
Moreno, María U.. (2011). The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes. Frontiers in Bioscience-Elite. E3(4). 1467–1474. 4 indexed citations
10.
José, Gorka San, Cristina Rodrı́guez, Anna Guadall, et al.. (2011). HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovascular Research. 92(2). 247–255. 41 indexed citations
11.
Moreno, María U. & Guillermo Zalba. (2010). CYBA gene variants as biomarkers for coronary artery disease. Drug News & Perspectives. 23(5). 316–316. 6 indexed citations
12.
Fortuño, Ana, María U. Moreno, Laura Montero, et al.. (2010). Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. Journal of Hypertension. 28(9). 1944–1950. 42 indexed citations
13.
Delles, Christian, Jane A. Dymott, Ulf Neisius, et al.. (2010). Reduced LDL-cholesterol levels in patients with coronary artery disease are paralelled by improved endothelial function: An observational study in patients from 2003 and 2007. Atherosclerosis. 211(1). 271–277. 19 indexed citations
14.
Moreno, María U., Óscar Beloqui, Nerea Varo, et al.. (2010). Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension. Journal of Hypertension. 28(11). 2219–2226. 6 indexed citations
15.
Zalba, Guillermo, Ana Fortuño, Gorka San José, et al.. (2007). Oxidative Stress, Endothelial Dysfunction and Cerebrovascular Disease. Cerebrovascular Diseases. 24(Suppl. 1). 24–29. 57 indexed citations
16.
Moreno, María U., Gorka San José, Ana Fortuño, et al.. (2007). A novel CYBA variant, the –675A/T polymorphism, is associated with essential hypertension. Journal of Hypertension. 25(8). 1620–1626. 29 indexed citations
17.
Moreno, María U., Gorka San José, Ana Fortuño, et al.. (2006). The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. Journal of Hypertension. 24(7). 1299–1306. 71 indexed citations
18.
Fortuño, Ana, Gorka San José, María U. Moreno, Javier Dı́ez, & Guillermo Zalba. (2005). Oxidative stress and vascular remodelling. Experimental Physiology. 90(4). 457–462. 125 indexed citations
19.
Cabré, Anna, Josefa Girona, Guillermo Zalba, et al.. (2004). Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit. Clinical Chemistry and Laboratory Medicine (CCLM). 42(4). 384–6. 8 indexed citations
20.
Moreno, María U., Gorka San José, Josune Orbe, et al.. (2003). Preliminary characterisation of the promoter of the human p22 phox gene: identification of a new polymorphism associated with hypertension. FEBS Letters. 542(1-3). 27–31. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026